Search research articles
Contact Us
Filters
Showing results (531-540 of 662) with videos related to
Page
of 67
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 16, 2022
ALiCE <sup>®</sup> : A versatile, high yielding and scalable eukaryotic cell-free protein synthesis (CFPS) system
Mainak Das Gupta, Yannick Flaskamp, Robin Roentgen, et al.
Clinical Therapeutics
|
September 21, 2002
A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement
Craig P Juergens, Harvey D White, Jorge A Belardi, et al.
Journal of the National Cancer Institute
|
January 9, 2026
Targeting common EGFR mutations in NSCLC-review of global phase III trials of third-generation inhibitors
Barbara Melosky, Rosalyn A Juergens, Quincy S C Chu, et al.
Immunotherapy
|
November 1, 2025
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
Courtney H Coschi, Keyue Ding, Dongsheng Tu, et al.
International Journal of Cancer
|
October 29, 2002
Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas
Toshifumi Ozaki, Karl-Ludwig Schaefer, Daniel Wai, et al.
European Journal of Medicinal Chemistry
|
August 11, 2020
Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies
Emanuele Gabellieri, Francesca Capotosti, Jerome Molette, et al.
FEMS Yeast Research
|
February 14, 2018
Genome editing in Kluyveromyces and Ogataea yeasts using a broad-host-range Cas9/gRNA co-expression plasmid
Hannes Juergens, Javier A Varela, Arthur R Gorter de Vries, et al.
Cancer Chemotherapy and Pharmacology
|
February 19, 2010
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
Paul K Paik, Charles M Rudin, Andrew Brown, et al.
Scientific Reports
|
November 7, 2024
Performance and safety evaluation of a cold ablation robot-guided laser osteotome (CARLO) in 28 midface osteotomies
Robert Köhnke, Shih-Jan Chin, Alexandre T Assaf, et al.
Current Oncology (Toronto, Ont.)
|
July 28, 2023
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer
Barbara L Melosky, Natasha B Leighl, David Dawe, et al.
Page
of 67
Search research articles
Search
Showing results (531-540 of 662) with videos related to
Sort By:
Page
of 67
Biorxiv : the Preprint Server for Biology
|
November 16, 2022
ALiCE <sup>®</sup> : A versatile, high yielding and scalable eukaryotic cell-free protein synthesis (CFPS) system
Mainak Das Gupta, Yannick Flaskamp, Robin Roentgen, et al.
Clinical Therapeutics
|
September 21, 2002
A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement
Craig P Juergens, Harvey D White, Jorge A Belardi, et al.
Journal of the National Cancer Institute
|
January 9, 2026
Targeting common EGFR mutations in NSCLC-review of global phase III trials of third-generation inhibitors
Barbara Melosky, Rosalyn A Juergens, Quincy S C Chu, et al.
Immunotherapy
|
November 1, 2025
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
Courtney H Coschi, Keyue Ding, Dongsheng Tu, et al.
International Journal of Cancer
|
October 29, 2002
Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas
Toshifumi Ozaki, Karl-Ludwig Schaefer, Daniel Wai, et al.
European Journal of Medicinal Chemistry
|
August 11, 2020
Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies
Emanuele Gabellieri, Francesca Capotosti, Jerome Molette, et al.
FEMS Yeast Research
|
February 14, 2018
Genome editing in Kluyveromyces and Ogataea yeasts using a broad-host-range Cas9/gRNA co-expression plasmid
Hannes Juergens, Javier A Varela, Arthur R Gorter de Vries, et al.
Cancer Chemotherapy and Pharmacology
|
February 19, 2010
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
Paul K Paik, Charles M Rudin, Andrew Brown, et al.
Scientific Reports
|
November 7, 2024
Performance and safety evaluation of a cold ablation robot-guided laser osteotome (CARLO) in 28 midface osteotomies
Robert Köhnke, Shih-Jan Chin, Alexandre T Assaf, et al.
Current Oncology (Toronto, Ont.)
|
July 28, 2023
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer
Barbara L Melosky, Natasha B Leighl, David Dawe, et al.
Page
of 67